Issue 11, Drugs & Dealers Magazine Released
Biotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Written By
Lea Bidiville
14 March 2017
Biotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreBiotech and Money are pleased to announce the release of the latest Drugs &...
Read MoreStraight from the Inv€$table CEO Pitch Breakfast hosted by K&L Gates on Tue...
Read MoreToday marks exactly 3 weeks until Britain makes one of its biggest decision...
Read MoreSome aspects of patent law of relevance to life sciences companies could co...
Read MoreThe Conservatives' 2015 election manifesto committed to hold a referendum b...
Read MoreDr. Jan-Anders Karlsson, CEO of Verona Pharma, shares company’s core focus ...
Read MoreIn an exclusive interview with Biotech and Money, Chris Yates,a prominent t...
Read MoreJames Wilkie, CEO of Birmingham Research Park,shines a spotlight on the Bir...
Read MoreFrancesco de Rubertis, Co-Founder and Partner of Medicxi Ventures, talks to...
Read MoreGraham Lumsden, CEO of Motif Bio, talks to Biotech and Money about the comm...
Read MoreBiotech and Money had the opportunity to talk with James Shaw, Co-Founder a...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
In partnership with Medius Associates
Medius' monthly review of the top deals by value in the healthcare sector
Connecting Europe's Life Science corporates with capital.
Biotech and Money is the influential community of senior life science decision makers
© 2016 All Rights Reserved By Biotech and Money
Add Your Response